Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development

Yunfeng Bai1, Hironori Edamatsu, Sakan Maeda

  • 1Division of Molecular Biology, Department of Molecular and Cellular Biology and Division of Molecular Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.

Cancer Research
|December 18, 2004
PubMed

Insights

Phospholipase C (PLC) epsilon plays a crucial role in skin cancer development. Inactivating PLC epsilon in mice significantly reduced tumor formation and progression, highlighting it as a potential anticancer drug target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • Ras proto-oncogenes are frequently mutated in skin cancers.
  • Downstream signaling pathways from Ras in skin carcinogenesis are not fully understood.
  • Phospholipase C (PLC) epsilon has been identified as a Ras effector.

Purpose of the Study:

  • To investigate the role of PLC epsilon in de novo skin chemical carcinogenesis.
  • To determine the impact of PLC epsilon genetic inactivation on tumor development and progression.
  • To explore PLC epsilon as a potential molecular target for anticancer drug development.

Main Methods:

  • Utilized genetically modified mice with inactivated PLC epsilon (PLCepsilon(-/-)).
  • Induced skin carcinogenesis using 7,12-dimethylbenz(a)anthracene (initiation) and 12-O-tetradecanoylphorbol-13-acetate (TPA) (promotion).
  • Analyzed tumor incidence, progression, Ha-ras gene mutations, and epidermal responses to TPA.

Main Results:

  • PLCepsilon(-/-) mice showed delayed onset and reduced incidence of skin squamous tumors.
  • Papillomas in PLCepsilon(-/-) mice failed to progress to carcinomas.
  • Ha-ras gene was mutationally activated in all analyzed tumors, regardless of PLC epsilon status.
  • PLCepsilon(-/-) skin did not exhibit basal layer cell proliferation or epidermal hyperplasia in response to TPA.

Conclusions:

  • PLC epsilon is essential for Ras oncogene-induced skin carcinogenesis.
  • PLC epsilon plays a critical role in downstream signaling from TPA.
  • PLC epsilon represents a promising molecular target for anticancer therapies in skin cancer.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...